<DOC>
	<DOCNO>NCT00359034</DOCNO>
	<brief_summary>We interest determine measure blood flow descend aorta ( large blood vessel abdomen ) healthy fetus fetuses growth restriction . An increase number adult disease ( e.g . heart blood vessel disease ) recognize potentially associate fetal growth development . Pulse wave velocity ( PWV ) measure blood flow blood vessel . This routinely measure adult , recently study child . The purpose study see develop simple ultrasound method measure PWV fetuses . The purpose study see consistently measure blood flow pattern fetal descend aorta ( large blood vessel abdomen ) 20 healthy fetus 20 growth restrict fetus use standard ultrasound technique .</brief_summary>
	<brief_title>Fetal Aortic Pulsewave Velocity : A Novel Doppler Ultrasound Method Measuring Biophysical Properties Fetal Aorta</brief_title>
	<detailed_description>Prospective subject recruit : 1 . Recruitment poster place DAP department BCWH . A contact number research nurse include recruitment poster interested subject contact . 2 . The antepartum inpatient unit BCWH . Prospective subject identify charge nurse patient satisfy inclusion exclusion criterion . Potential subject ask charge nurse interested meeting study investigator research nurse information . 3 . The subject participate twice study , 28 week 28 week , long 3 week pass study period . All subject participate 28 week ask consent process interested participate second time . Subjects agreement contact study nurse phone arrange second appointment . Study Procedure Subject Involvement Measuring PWV require place 3 electrocardiography ( ECG ) lead maternal abdomen various position detect fetal ECG signal . We establish fetal ECG signal detect small deflection maternal ECG tracing . The fetal ECG signal allow u correlate blood flow wave form descend aorta fetal cardiac cycle . The onset blood flow waveform assess two point ( A B ) along descend aorta use standard pulse Doppler ultrasound technique . Point A aortic isthmus Point B beyond level renal artery . Measurements obtain follow sequence : 1 ) time require waveform travel Point A Point B ; 2 ) distance ( mm ) Point A Point B ; 3 ) fetal heart rate use M-mode . The time take waveform travel measure distance point A B , allow u calculate PWV portion fetal aorta . This sequence measurement repeat three time fetus . Subject Protocol 1 . Subjects ask drink 500 cc water prior arrival appointment ensure adequate hydration ( affect amniotic fluid volume ) . 2 . Subjects ask void prior enter study room . 3 . Subjects place left lateral decubitus supine position 4 . Subjects rest 15 minute prior start ultrasound examination . At time , consent review , demographic information record . 5 . ECG electrodes applied maternal abdomen 6 . Fetal biometry , AFI umbilical artery Dopplers perform ( do within past 48 hour ) . 7 . PWV determine three time , within 10 minute . The demographic pregnancy information collect include : 1. maternal age 2. gestational age time study 3. obstetrical history ( gravida , term , preterm , abortus , live ) 4. maternal smoke history 5. amniotic fluid volume 6. estimate fetal weight and/or growth parameter percentiles The following information collect record study ultrasound : 1. time require obtain PWV measurement 2. calculate PWV 3. maternal blood pressure pulse 4. fetal presentation 5. fetal heart rate 6. presence absence fetal activity breathe study 7 . AFI UA Doppler waveform .</detailed_description>
	<criteria>Study Group N : Singleton pregnancy 20 week 0 day 36 week 0 day Normal obstetrical ultrasound DAP BCWH 2036 week GA Study Group IUGR : Singleton pregnancy 20 week 0 day 36 week 0 day Obstetrical ultrasound DAP BCWH 2036 week GA demonstrate IUGR ( abdominal circumference AC &lt; 10 % ) one : ) oligohydramnios ( amniotic fluid index ( AFI ) &lt; 5 % ) b ) abnormal umbilical artery ( UA ) Dopplers ( absent reverse enddiastolic flow ) Study Group N : Gestational age &lt; 20 week ≥36 week Multiple pregnancy Any know suspected fetal structural anomaly ( include cardiac ) Chromosomal abnormality ( amniocentesis CVS ) Abnormalities fetal growth ( AC &lt; 10 % ; AC &gt; 90 % ) Abnormalities amniotic fluid volume ( AFI &lt; 5 % &gt; 95 % ) Maternal hypertensive disorder ( prior pregnancy ) Illicit drug use pregnancy ( cocaine , heroin , methamphetamine ) Maternal medical history chronic illness require medication ( eg lupus , asthma , etc . ) Abnormal maternal serum triple screen ( AFP ≥2.5MoM , hCG &gt; 3.0 MoM ) Study Group IUGR : Gestational age &lt; 20 week ≥36 week Multiple pregnancy Any know suspected fetal structural anomaly ( include cardiac ) Chromosomal abnormality ( amniocentesis CVS ) Normal fetal growth AC ≥10 % Illicit drug use pregnancy ( cocaine , heroin , methamphetamine )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Doppler ultrasound</keyword>
	<keyword>pulsewave velocity</keyword>
	<keyword>intrauterine growth restriction</keyword>
	<keyword>Fetal Pulsewave Velocity</keyword>
</DOC>